Early signs of progress in osteosarcoma research
Recent research into osteosarcoma has identified shared cell surface markers that could lead to new targeted therapies for bone cancer. While current treatment options remain limited, these findings offer potential pathways for antibody-drug conjugates and other precision medicine approaches.
Why it matters
Osteosarcoma has seen little progress in treatment over the last two decades; identifying new molecular targets is critical for improving survival rates in young patients.
Emerging molecular and spatial approaches are providing new insights into osteosarcoma and identifying potential targets for future therapies
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in